You are here:
celecoxib (Celebrex)
Advice
In the absence of a submission from the holder of the marketing authorisation
celecoxib (Celebrex®) is not recommended for use within NHSScotland for ankylosing spondylitis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
- Detailed Advice (PDF)
There is no press statement for this advice.
Drug Details
| Drug Name: | celecoxib (Celebrex) |
|---|---|
| SMC Drug ID: | 410/07 |
| Manufacturer: | Pfizer Ltd |
| Indication: | ankylosing spondylitis. |
| BNF Category: | |
| Sub Category: | 10.1 Drugs used in rheumatic diseases and gout |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 10 September 2007 |